Skip to main content
. 2017 Jun 10;8(3):293–299. doi: 10.5306/wjco.v8.i3.293

Table 1.

Prognoses of pancreatic neuroendocrine tumor Grade 1 patients

Sex Age (yr) Initial size (mm) Location of tumor Method of final diagnosis Ki-67 index (%) Mitotic count (/10 HPFs) Function Elevated tumor markers Observation period (mo) Tumor growth (mm)
1 F 79 19 Body Surgery < 2.0 0 No No 6 No
2 F 41 34 Tail Surgery 0.9 2 Yes No 80 76
3 M 69 3 Body Surgery < 2.0 0 Yes No 15 No
4 M 55 40 Head Surgery < 1.0 0 Yes No 6 No
5 F 73 32 Head Surgery 1.3 0 No No 9 No
6 F 81 4 Head EUS-FNA < 1.0 Difficult No No 22 No
7 F 64 8 Tail EUS-FNA 0.4 Difficult No No 17 No
8 F 70 8 Body EUS-FNA < 1.0 Difficult No No 54 No

M: Male; F: Female; EUS-FNA: Endoscopic ultrasonography-guided fine needle aspiration.